Thinking through this more- aren’t most CRC tumors CDK 4/6 dependent, vs SCLC and TNBC? Why did they think this wouldn’t be a major risk to efficacy? Because they thought they could offset the toxicity of the 5FU and allow for greater exposure?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.